190 related articles for article (PubMed ID: 33275732)
61. SHORT syndrome in an adult Brazilian patient.
Gonçalves ACG; Moretti PN; Cordoba MS; Oliveira RS; Lopes FSC; Oliveira SF; Pic-Taylor A; Castro LC; Mazzeu JF
Am J Med Genet A; 2022 May; 188(5):1635-1638. PubMed ID: 35080105
[TBL] [Abstract][Full Text] [Related]
62. Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.
Vasko T; Kaifie A; Stope MB; Kraus T; Ziegler P
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29143804
[TBL] [Abstract][Full Text] [Related]
63. The short and long telomere syndromes: paired paradigms for molecular medicine.
Stanley SE; Armanios M
Curr Opin Genet Dev; 2015 Aug; 33():1-9. PubMed ID: 26232116
[TBL] [Abstract][Full Text] [Related]
64. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.
Alter BP; Baerlocher GM; Savage SA; Chanock SJ; Weksler BB; Willner JP; Peters JA; Giri N; Lansdorp PM
Blood; 2007 Sep; 110(5):1439-47. PubMed ID: 17468339
[TBL] [Abstract][Full Text] [Related]
65. Telomerase mutations in smokers with severe emphysema.
Stanley SE; Chen JJ; Podlevsky JD; Alder JK; Hansel NN; Mathias RA; Qi X; Rafaels NM; Wise RA; Silverman EK; Barnes KC; Armanios M
J Clin Invest; 2015 Feb; 125(2):563-70. PubMed ID: 25562321
[TBL] [Abstract][Full Text] [Related]
66. Germline mutation of
Toufektchan E; Lejour V; Durand R; Giri N; Draskovic I; Bardot B; Laplante P; Jaber S; Alter BP; Londono-Vallejo JA; Savage SA; Toledo F
Sci Adv; 2020 Apr; 6(15):eaay3511. PubMed ID: 32300648
[TBL] [Abstract][Full Text] [Related]
67. Running short on time: lung transplant evaluation for telomere-related pulmonary fibrosis.
Garcia CK
Chest; 2015 Jun; 147(6):1450-1452. PubMed ID: 26033121
[No Abstract] [Full Text] [Related]
68. SHORT Syndrome: an Update on Pathogenesis and Clinical Spectrum.
Shvalb NF
Curr Diab Rep; 2022 Dec; 22(12):571-577. PubMed ID: 36401775
[TBL] [Abstract][Full Text] [Related]
69. Alternative paths to telomere elongation.
Lee JJ; Lee J; Lee H
Semin Cell Dev Biol; 2021 May; 113():88-96. PubMed ID: 33293233
[TBL] [Abstract][Full Text] [Related]
70. Senescence in Pulmonary Fibrosis: Between Aging and Exposure.
Venosa A
Front Med (Lausanne); 2020; 7():606462. PubMed ID: 33282895
[TBL] [Abstract][Full Text] [Related]
71. Management of AL amyloidosis in 2020.
Palladini G; Milani P; Merlini G
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):363-371. PubMed ID: 33275753
[TBL] [Abstract][Full Text] [Related]
72. Rituximab and eculizumab when treating nonmalignant hematologic disorders: infection risk, immunization recommendations, and antimicrobial prophylaxis needs.
Engel ER; Walter JE
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):312-318. PubMed ID: 33275746
[TBL] [Abstract][Full Text] [Related]
73. Outpatient transfusions for myelodysplastic syndromes.
Wood EM; McQuilten ZK
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):167-174. PubMed ID: 33275745
[TBL] [Abstract][Full Text] [Related]
74. Challenges in chronic transfusion for patients with thalassemia.
Lal A
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):160-166. PubMed ID: 33275743
[TBL] [Abstract][Full Text] [Related]
75. Fundamentals of immunology for understanding immunotherapy for lymphoma.
Ansell SM
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):585-589. PubMed ID: 33275742
[TBL] [Abstract][Full Text] [Related]
76. Combining antiplatelet and anticoagulant therapy in cardiovascular disease.
Barnes GD
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):642-648. PubMed ID: 33275740
[TBL] [Abstract][Full Text] [Related]
77. Monoclonal gammopathies of clinical significance.
Dispenzieri A
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):380-388. PubMed ID: 33275738
[TBL] [Abstract][Full Text] [Related]
78. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?
Áinle FN; Kevane B
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):201-212. PubMed ID: 33275736
[TBL] [Abstract][Full Text] [Related]
79. Bispecifics, trispecifics, and other novel immune treatments in myeloma.
Lancman G; Richter J; Chari A
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):264-271. PubMed ID: 33275733
[TBL] [Abstract][Full Text] [Related]
80. Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders.
Pennington KM; Simonetto D; Taner T; Mangaonkar AA
Curr Hematol Malig Rep; 2024 Feb; ():. PubMed ID: 38315384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
